Celularity Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-77.4% -$14M
$4M
Cost of Revenue↑+0.4% +$31K
$7M
Gross Profit
—
R&D↓-12.6% -$481K
$3M
SG&A↓-6.2% -$994K
$15M
D&A↓-3.9% -$73K
$2M
Operating Income↓-11.9% -$1M
$-13M
EBITDA↓-3.9% -$73K
$2M
Interest Income
—
Other Income/Expense↓-122.6% -$6M
$-10M
Pretax Income↓-43.3% -$7M
$-23M
Tax Provision
$3K
Net Income↓-43.3% -$7M
$-23M
Gross Margin
—
Operating Margin↓-120.1pts
-244.1%
Net Margin↓-263.5pts
-436.7%
Effective Tax Rate
0.0%
Deferred Tax Liabilities
$3K
ETR (Continuing Operations)
—
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
-1.3%
Operating Lease Cost↑+0.0% +$0
$978K
Revenue YoY Variation↓-127.1pts
-77.4%
Income YoY Variation↓-100.3pts
-11.9%
Revenue QoQ Variation↓-117.4pts
-22.3%
Income QoQ Variation↑+32.0pts
18.7%